Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Bauer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Circulation. Cardiovascular Genetics|December 4, 2010
Mutations in the sarcomere gene MYH7 in Ebstein anomalyAlex V Postma, Klaartje van Engelen, Judith van de Meerakker, et al.
World Journal of Gastroenterology|July 9, 2021
High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapyUlrike Bauer, Sabine Gerum, Falk Roeder, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Gut|May 12, 2025
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancerThomas Rösner, Carina Rupp, Christian Lechler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.
NPJ Genomic Medicine|June 2, 2026
Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome studyEnrique Audain, Anna Wilsdon, Gregor Dombrowsky, et al.
Cell Chemical Biology|November 29, 2024
An engineered cereblon optimized for high-throughput screening and molecular glue discoveryHenry J Bailey, Jonathan Eisert, Rubina Kazi, et al.
Genome Medicine|January 8, 2026
DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defectsGregor Dombrowsky, Liselot van der Laan, Ananília Silva, et al.
Cancers|March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter StudyChristian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Therapeutic Advances in Medical Oncology|February 24, 2026
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Circulation. Cardiovascular Genetics|December 4, 2010
Mutations in the sarcomere gene MYH7 in Ebstein anomalyAlex V Postma, Klaartje van Engelen, Judith van de Meerakker, et al.
World Journal of Gastroenterology|July 9, 2021
High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapyUlrike Bauer, Sabine Gerum, Falk Roeder, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Gut|May 12, 2025
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancerThomas Rösner, Carina Rupp, Christian Lechler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.
NPJ Genomic Medicine|June 2, 2026
Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome studyEnrique Audain, Anna Wilsdon, Gregor Dombrowsky, et al.
Cell Chemical Biology|November 29, 2024
An engineered cereblon optimized for high-throughput screening and molecular glue discoveryHenry J Bailey, Jonathan Eisert, Rubina Kazi, et al.
Genome Medicine|January 8, 2026
DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defectsGregor Dombrowsky, Liselot van der Laan, Ananília Silva, et al.
Cancers|March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter StudyChristian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Therapeutic Advances in Medical Oncology|February 24, 2026
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch, et al.
Pageof 10